News

TECHLAB Marketing Manager, Jodie Lee, to lead a C. difficile workshop during the SCACM 2020 Spring Meeting

C. difficile is the leading cause of hospital-acquired infections and greatly influences hospital infection rates and patient treatment protocols. Jodie Lee, MBA, MS, Marketing Manager at TECHLAB will lead a discussion on C. difficile testing algorithms and best practices for healthcare systems. The complimentary educational session will occur during the SCACM 2020 Spring Meeting in … Continue reading

February 27, 2020

TECHLAB participates in filming video to accompany manuscript

TECHLAB scientists Janice Buss, PhD and Michelle Santiago participated in filming a video that will accompany a manuscript on Campylobacter culture methods to determine the detection and survival of Campylobacter jejuni from human fecal specimens in transport media. Stay tuned for links to the manuscript and the video, both of which will be available soon!… Continue reading

January 21, 2020

Product Spotlight: C. DIFF QUIK CHEK COMPLETE

When used as a front line test in a two-step algorithm, the C. DIFF QUIK CHEK COMPLETE test dramatically reduced Torrance Memorial Medical Center’s standard infection ratio average from 1.3 to 0.3, markedly below the national average. Read the full article here… Continue reading

October 24, 2019

TECHLAB is proud to be a silver sponsor of the C. diff Conference and Health Expo

TECHLAB is proud to support the C. diff Foundation, a non-profit organization that advocates for C. difficile infection (CDI) prevention, treatments, clinical trials, and environmental safety worldwide. The 7th annual C. diff Conference and Health Expo brings together leading international healthcare professionals, executives, physicians, researchers, academics, clinical trial professionals, and health advocates to discuss health … Continue reading

October 1, 2019

Check out Dr. David Lyerly’s appearance on C. diff Spores and More

Check out the edited video version below… Continue reading

September 9, 2019

New research from the UVa School of Medicine links host immune response and Inflammatory Bowel Disease (IBD) to C. difficile severity

Read the entire article here: https://newsroom.uvahealth.com/2019/04/22/revealed-the-secret-superpower-that-makes-c-difficile-so-deadly… Continue reading

May 2, 2019

Dr. David Lyerly and James Boone appear as guests on C. diff Spores and More

On Tuesday, March 19, Dr. David Lyerly and James Boone joined Nancy Caralla, Executive Director of the C. diff Foundation, on the C. diff radio broadcast of Spores and More. Together, they discussed C. difficile research, clinical assays, autoimmune diseases including Inflammatory Bowel Disease, and C. difficile guidelines. Listen to the full episode here… Continue reading

March 20, 2019

Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods

To read the full manuscript, click here… Continue reading

March 8, 2019

TECHLAB COO Robert Day elected to the board of Virginia Bio

TECHLAB Chief Operating Officer Robert Day has been elected to the board of Virginia Bio, the premier statewide non-profit association representing the life science industry in Virginia. Congratulations, Rob! Read the full article her… Continue reading

January 4, 2019

Dr. Bincy P. Abraham explains the benefits of fecal lactoferrin

Gastroenterology & Hepatology recently featured an interview with Dr. Bincy P. Abraham, Director of the Gastroenterology Fellowship Program at Houston Methodist. Dr. Abraham explains the benefits of fecal lactoferrin testing and how lactoferrin testing can help manage patients with IBD. Read the entire interview here… Continue reading

December 17, 2018

What we are up to: